Zhewen Wei
State Key Laboratory Of Molecular Oncology, Chinese Academy Of Medical Sciences And Peking Union Medical College
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Glucose restriction reprograms lipid metabolism and enhances immunotherapy through ZNRF3-Wnt-SCD signaling axis.
Journal: Journal for immunotherapy of cancer
Published: May 16, 2026
Landscape of Somatic and Age-Related Pathogenic Structural Variations in Hepatocellular Carcinoma Revealed by Long-Read Sequencing.
Journal: MedComm
Published: January 02, 2025
HBV integrations reshaping genomic structures promote hepatocellular carcinoma.
Journal: Gut
Published: June 07, 2023
Epidemiology of adenosarcoma and the inverse probability of treatment weighting (IPTW) adjusted survival analysis of lymph node dissection in uterine adenosarcoma.
Journal: Medicine
Published: October 05, 2022
Correction: AHR mediates the Aflatoxin B1 toxicity associated with hepatocellular carcinoma.
Journal: Signal transduction and targeted therapy
Published: December 20, 2021
Serum alpha-fetoprotein as a predictive biomarker for tissue alpha-fetoprotein status and prognosis in patients with hepatocellular carcinoma.
Journal: Translational cancer research
Published: October 24, 2021
The prognostic factors of primary colorectal sarcoma and the clinical outcomes of negative lymph node dissection.
Journal: Annals of translational medicine
Published: March 12, 2021
AHR mediates the aflatoxin B1 toxicity associated with hepatocellular carcinoma.
Journal: Signal transduction and targeted therapy
Published: March 01, 2021
Neoadjuvant radiotherapy for resectable hepatocellular carcinoma with portal vein tumor thrombus: a systematic review.
Journal: Hepatobiliary surgery and nutrition
Published: December 20, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026